Trial Profile
Data Collection on Hypertension and Its Treatment With Kinzal/ Kinzalplus.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Sep 2013
Price :
$35
*
At a glance
- Drugs Telmisartan (Primary) ; Telmisartan/hydrochlorothiazide (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Bayer
- 03 Nov 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Nov 2011 Actual end date (Oct 2011) added as reported by ClinicalTrials.gov.
- 15 Jul 2010 Planned end date changed from 1 Apr 2010 to 1 Jul 2011 as reported by ClinicalTrials.gov.